Nitric oxide gas infusion to the oxygenator enhances the biocompatibility of heparin coated extracorporeal bypass circuits

ASAIO Journal

Volumn 44, Issue 5, 1998, Pages

  Hayashi, Yoshitaka ^a   Sawa, Yoshiki ^a   Nishimura, Motonobu ^a   Chang, Jau Chang ^a   Amemiya, Akira ^a   Kagisaki, Koji ^a   Taketani, Satoshi ^a   Yamaguchi, Takahiro ^a   Hirata, Nobuaki ^a   Ohtake, Shigeaki ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; NITROGEN OXIDES; OXYGENATORS;

GAS INFUSION; HEPARIN;

BIOLOGICAL MATERIALS;

ALPHA 2 ANTIPLASMIN; BETA THROMBOGLOBULIN; BRADYKININ; COMPLEMENT COMPONENT C3; ELASTASE; HEPARIN; NITRATE; NITRIC OXIDE; NITRITE; PLASMINOGEN ACTIVATOR INHIBITOR; SEROTONIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFLAMMATION; OXYGENATION; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0032169964     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199809000-00027     Document Type: Article

References (30)

1. Colman RW, Scott CF, Schaler AH, Wachtfogel YT, Pixley RA, Edmunds LH: Initiation of blood coagulation at artificial surfaces. Ann N Y Acad Sci 56: 253-267, 1987.
2. Addonizio VP: Platelet function in cardiopulmonary bypass and artificial organs. Hematol Oncol Clin North Am 4: 145-155, 1990.
3. Kirklin JK: Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 51: 529-531, 1991.
4. Downing SW, Edmunds LH Jr: Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 54: 1236-1243, 1992.
5. Ohata T, Sawa Y, Kadoba K, Masai T, Ichikawa H, Matsuda H: Effect of cardiopulmonary bypass under tepid temperature on inflammatory reactions. Ann Thorac Surg 64: 124-128, 1997.
6. Teoh KH, Bradley CA, Gauldie J, Burrows H: Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 92(Suppl II): II-347-II-353, 1995.
7. Sawa Y, Shimazaki Y, Kadoba K, et al: Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 111: 29-35, 1996.
8. Moen O, Fosse E, Dregelid E, et al: Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg 62: 1134-1140, 1996.
9. Ovrum E, Brosstad F, Holen EA, Tangen G, Abdelnoor M: Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation 92: 2579-2584, 1995.
10. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson HE: Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 104: 642-647, 1992.
11. Steinberg BM, Grossi EA, Schwartz DS, et al: Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 60: 525-529, 1995.
12. Ovrum E, Holen EA, Tangen G, et al: Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. Ann Thorac Surg 60: 365-371, 1995.
13. Kagisaki K, Masai T, Kadoba K, et al: Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. Artif Organs 21: 836-840, 1997.
14. Ihno T, Nakagawa T, Furukawa H, et al: Various problems during long-term percutaneous cardiopulmonary support. Artif Organs 21: 766-771, 1997.
15. Weight CD, Mulsch A, Busse R, Osswald H: Generation of nitric oxide by human neutrophil. Biochem Biophys Res Commun 160: 813-819, 1989.
16. Samuni A, Winkelberg D, Pinson A: Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Invest 87: 1526-1530, 1991:
17. Niu X, Smith CW, Kubes P: Intercellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74: 1133-1140, 1994.
18. Fukuda H, Sawa Y, Kadoba K, Taniguchi K, Shimazaki Y, Matsuda H: Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 92(Suppl II): II-413-II-416, 1995.
19. Sly MK, Prager MD, Li J, et al: Platelet and neutrophil distributions in pump oxygenator circuits. III. Influence of nitric oxide gas infusion. ASAIO J 42: M494-M499, 1996:
20. Konishi R, Shimizu R, Firestone I, et al: Nitric oxide prevents human platelet adhesion to fiber membranes in whole blood. ASAIO J 42: M850-M853, 1996.
21. Mellgren K, Friberg LG, Mellgren G, Hedner T, Wennmalm A, Wadenvik H: Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 61: 1194-1198, 1996.
22. Fukuyama N, Ichimori K, Su Z, Ishida H, Nakazawa Y: Peroxynitrite formation from activated human leukocytes. Biochem Biophys Res Commun 224: 414-419, 1996.
23. John LCH, Rees GM, Kovacs IB: Inhibition of platelet function by heparin: an etiologic factor in post bypass hemorrhage. J Thorac Cardiovasc Surg 105: 816-822, 1993.
24. Radomski MW, Palmer RMJ, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 7: 1057-1058, 1987.
25. Buechler WA, Ivanova K, Wolfram G, Drummer C, Heim JM, Gerzer R: Soluble guanylate cyclase and platelet function. Ann N Y Acad Sci 106: 507-508, 1994.
26. Johnson D, Thomson D, Hurst T, et al: Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg 107: 1193-1202, 1994.
27. Abdih H, Kelly CJ, Boucheier-Hayes D, et al: Nitric oxide (endothelium-derived relaxing factor) attenuates revascularization-induced lung injury. J Surg Res 1994: 39-43, 1994.
28. Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW: Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric-oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167, 1995.
29. Ischiropoulos H, Zhu L, Beckman JS: Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298: 446-451, 1992.
30. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS: Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 151: 1250-1254, 1995.